Journal List > Allergy Asthma Respir Dis > v.7(1) > 1125519

Allergy Asthma Respir Dis. 2019 Jan;7(1):51-56. Korean.
Published online Jan 30, 2019.  https://doi.org/10.4168/aard.2019.7.1.51
© 2019 The Korean Academy of Pediatric Allergy and Respiratory Disease; The Korean Academy of Asthma, Allergy and Clinical Immunology
Clinical characteristics of pediatric pneumothorax during a noninvasive positive pressure ventilation
Bo Ra Lee,1 So Hyun Shin,1 Min Jung Kim,1 Eunji Kim,1 Yun Jung Choi,2 June Dong Park,1 and Dong In Suh1
1Department of Pediatrics, Seoul National University Children's Hospital, Seoul, Korea.
2Sowha Children's Hospital, Seoul, Korea.

Correspondence to: Eunji Kim. Department of Pediatrics, Seoul National University Children's Hospital, 101 Daehak-ro, Jongno-gu, Seoul 03080, Korea. Tel: +82-2-2072-3778, Fax: +82-2-2072-3917, Email: mdkim78@naver.com
Received Sep 28, 2018; Revised Oct 22, 2018; Accepted Oct 22, 2018.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/).


Abstract

Purpose

Noninvasive positive pressure ventilation (NIPPV) is one of the ventilation-supporting methods by providing adequate exogenous pressure without intubation or tracheostomy. We aimed to assess the frequency and clinical factors for pneumothorax occurring during NIPPV application in a tertiary children's hospital.

Methods

We selected cases of pneumothorax related to NIPPV by keyword searching in our institution's clinical data warehouse, and their medical records were retrospectively reviewed.

Results

During a period of 17 years, 15 cases undergoing NIPPV developed pneumothorax, which was an incidence of 0.64% (15 of 2,343). There were 9 neonates and 6 adolescents. In 9 neonates, pneumothorax was caused by the continuous positive airway pressure (CPAP) ventilator, and occurred on 2 days after birth (median, range 1–3 days). In neonates, pneumothorax developed within 36 hours after CPAP application. One neonate underwent tracheal intubation and 3 neonates underwent chest tube insertion. In the postteenager group, pneumothorax developed 23 months (median, range 5 days to 47 months) after NIPPV application with a mask. All of the 6 patients had underlying neuromuscular disorders and one had superimposed interstitial lung disease. One of the 7 cases underwent surgical treatment and 4 cases were intubated. One case died from the deterioration of underlying interstitial lung disease.

Conclusion

Although it rarely happens, the NIPPV can result in pneumothorax. In most cases, it can be resolved by supportive cares with oxygen or chest tube with or without tracheostomy. The prognosis is related to the type of underlying disease and its progression.

Keywords: Noninvasive ventilation; Pneumothorax; Respiratory insufficiency

Figures


Fig. 1
Flow chart of subjects being anlyzed. NIPPV, noninvasive positive pressure ventilation; NICU, neonatal intensive care unit.
Click for larger imageDownload as PowerPoint slide

Tables


Table 1
Keywords used in defining the case of pneumothorax associated with the noninvasive positive airway pressure ventilatory support
Click for larger imageClick for full tableDownload as Excel file


Table 2
Demographic and clinical characteristics of study patients
Click for larger imageClick for full tableDownload as Excel file


Table 3
Comparison of ventilator mode and setting values between the 2 groups
Click for larger imageClick for full tableDownload as Excel file


Table 4
Comparison of treatment and procedures between the 2 groups
Click for larger imageClick for full tableDownload as Excel file

References
1. Wolfler A, Calderini E, Iannella E, Conti G, Biban P, Dolcini A, et al. Evolution of noninvasive mechanical ventilation use: a cohort study among Italian PICUs. Pediatr Crit Care Med 2015;16:418–427.
2. Gregoretti C, Pisani L, Cortegiani A, Ranieri VM. Noninvasive ventilation in critically ill patients. Crit Care Clin 2015;31:435–457.
3. Organized jointly by the American Thoracic Society, the European Respiratory Society, the European Society of Intensive Care Medicine, and the Société de Réanimation de Langue Française, and approved by ATS Board of Directors, December 2000. International Consensus Conferences in Intensive Care Medicine: noninvasive positive pressure ventilation in acute Respiratory failure. Am J Respir Crit Care Med 2001;163:283–291.
4. British Thoracic Society Standards of Care Committee. Non-invasive ventilation in acute respiratory failure. Thorax 2002;57:192–211.
5. Carron M, Freo U, BaHammam AS, Dellweg D, Guarracino F, Cosentini R, et al. Complications of non-invasive ventilation techniques: a comprehensive qualitative review of randomized trials. Br J Anaesth 2013;110:896–914.
6. Najaf-Zadeh A, Leclerc F. Noninvasive positive pressure ventilation for acute respiratory failure in children: a concise review. Ann Intensive Care 2011;1:15.
7. Ozsancak A, D’Ambrosio C, Hill NS. Nocturnal noninvasive ventilation. Chest 2008;133:1275–1286.
8. Ward S, Chatwin M, Heather S, Simonds AK. Randomised controlled trial of non-invasive ventilation (NIV) for nocturnal hypoventilation in neuromuscular and chest wall disease patients with daytime normocapnia. Thorax 2005;60:1019–1024.
9. Simonds AK, Muntoni F, Heather S, Fielding S. Impact of nasal ventilation on survival in hypercapnic Duchenne muscular dystrophy. Thorax 1998;53:949–952.
10. Czell DC. Daytime mouthpiece ventilation plus nighttime noninvasive ventilation improves quality of life in patients with neuromuscular disease. Respir Care 2014;59:1460–1461.
11. Mellies U, Ragette R, Dohna Schwake C, Boehm H, Voit T, Teschler H. Long-term noninvasive ventilation in children and adolescents with neuromuscular disorders. Eur Respir J 2003;22:631–636.
12. Mayordomo-Colunga J, Pons-Òdena M, Medina A, Rey C, Milesi C, Kallio M, et al. Non-invasive ventilation practices in children across Europe. Pediatr Pulmonol 2018;53:1107–1114.
13. Ergan B, Nasiłowski J, Winck JC. How should we monitor patients with acute respiratory failure treated with noninvasive ventilation? Eur Respir Rev 2018;27(148):pii: 170101 [doi: 10.1183/16000617.0101-2017]
14. Haworth CS, Dodd ME, Atkins M, Woodcock AA, Webb AK. Pneumothorax in adults with cystic fibrosis dependent on nasal intermittent positive pressure ventilation (NIPPV): a management dilemma. Thorax 2000;55:620–622.
15. Simonds AK. Pneumothorax: an important complication of non-invasive ventilation in neuromuscular disease. Neuromuscul Disord 2004;14:351–352.
16. Crulli B, Loron G, Nishisaki A, Harrington K, Essouri S, Emeriaud G. Safety of paediatric tracheal intubation after non-invasive ventilation failure. Pediatr Pulmonol 2016;51:165–172.
17. Hishikawa K, Goishi K, Fujiwara T, Kaneshige M, Ito Y, Sago H. Pulmonary air leak associated with CPAP at term birth resuscitation. Arch Dis Child Fetal Neonatal Ed 2015;100:F382–F387.
18. Trevisanuto D, Doglioni N, Ferrarese P, Vedovato S, Cosmi E, Zanardo V. Neonatal pneumothorax: comparison between neonatal transfers and inborn infants. J Perinat Med 2005;33:449–454.
19. Diblasi RM. Nasal continuous positive airway pressure (CPAP) for the respiratory care of the newborn infant. Respir Care 2009;54:1209–1235.
20. Buckmaster AG, Arnolda G, Wright IM, Foster JP, Henderson-Smart DJ. Continuous positive airway pressure therapy for infants with respiratory distress in non tertiary care centers: a randomized, controlled trial. Pediatrics 2007;120:509–518.
21. Morley CJ, Davis PG, Doyle LW, Brion LP, Hascoet JM, Carlin JB, et al. Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med 2008;358:700–708.
22. Davis PG, Henderson-Smart DJ. Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants. Cochrane Database Syst Rev 2003;(2):CD000143
23. Dargaville PA, Gerber A, Johansson S, De Paoli AG, Kamlin CO, Orsini F, et al. Incidence and outcome of CPAP failure in preterm infants. Pediatrics 2016;138
24. Nørregaard O. Noninvasive ventilation in children. Eur Respir J 2002;20:1332–1342.
25. Chatwin M, Tan HL, Bush A, Rosenthal M, Simonds AK. Long term non-invasive ventilation in children: impact on survival and transition to adult care. PLoS One 2015;10:e0125839
26. Simonds AK, Ward S, Heather S, Bush A, Muntoni F. Outcome of paediatric domiciliary mask ventilation in neuromuscular and skeletal disease. Eur Respir J 2000;16:476–481.
27. Leger P, Bedicam JM, Cornette A, Reybet-Degat O, Langevin B, Polu JM, et al. Nasal intermittent positive pressure ventilation. Long-term follow-up in patients with severe chronic respiratory insufficiency. Chest 1994;105:100–105.
28. Hsu CW, Sun SF. Iatrogenic pneumothorax related to mechanical ventilation. World J Crit Care Med 2014;3:8–14.
29. da Silva PS, de Aguiar VE, Fonseca MC. Iatrogenic pneumothorax in mechanically ventilated children: Incidence, risk factors and other outcomes. Heart Lung 2015;44:238–242.
30. Vianello A, Arcaro G, Gallan F, Ori C, Bevilacqua M. Pneumothorax associated with long-term non-invasive positive pressure ventilation in Duchenne muscular dystrophy. Neuromuscul Disord 2004;14:353–355.